US Health Strategy Group
Clinical strategy for healthcare innovation that needs trust before scale.
US Health Strategy Group helps emerging healthcare, medtech, neuromodulation, and AI health companies move from innovation to trusted adoption through clinical strategy, KOL infrastructure, research design, and commercialization support.
The wedge
Innovation does not fail only because the product is weak. It fails when adoption, evidence, workflow, and trust are not built around it.
Clinical leaders need to understand where the technology fits.
Companies need credible KOL infrastructure before broad market claims.
Research and commercial strategy need to connect without crossing compliance boundaries.
Services
Built for companies entering complex healthcare markets.
KOL Network Development
Building compliant physician, provider, and clinical advisor networks around education, evidence, adoption, and market readiness.
Learn more →
Neuromodulation & Advanced Therapy Strategy
Supporting companies working across VNS, taVNS, PNS, non-invasive stimulation, regenerative pathways, and advanced therapy adoption.
Learn more →
Research & SOW Development
Translating innovation into structured scopes of work, research concepts, clinical workflow maps, and outcome strategy.
Learn more →
Commercialization & Market Access
Helping emerging healthcare companies move from product promise to provider trust, adoption, and market execution.
Learn more →
Positioning
A practical bridge between clinical credibility and commercial execution.
USHSG is not a marketing agency. It is a strategy group focused on clinical adoption, KOL development, research readiness, and commercialization support for healthcare companies where trust, evidence, workflow, and access matter.
Build trust before scale
Move from innovation to trusted adoption.
US Health Strategy Group helps emerging healthcare companies structure the clinical, commercial, and advisory infrastructure needed for responsible growth.
Start a conversation